1. Albany Molecular Research, Inc. (32 from 97 patents)

2. Bristol-myers Squibb Compnay (7 from 3,684 patents)

3. Merck Sharp + Dohme Corp. (4 from 2,405 patents)

4. Astrazeneca Ab (4 from 1,500 patents)

5. Eli Lilly and Company (3 from 4,446 patents)

6. Zenith Epigenetics Corp. (1 from 24 patents)

7. Amr Technology, Inc. (1 from 23 patents)

8. Sequoia Sciences, Inc. (1 from 15 patents)

9. Harmony Biosciences, Inc. (1 patent)

10. Curia Global, Inc. (0 patent)

1. 10231953 - Inhibitors of bromodomains

2. 9650378 - (1-azinone)-substituted pyridoindoles

3. 9562031 - Phenethyldihydrobenzodioxolones and methods of use

4. 9499531 - Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

5. 9403776 - Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

6. 9352049 - Ligand-therapeutic agent conjugates, silicon-based linkers, and methods for making and using them

7. 9296743 - (1-azinone)-substituted pyridoindoles

8. 9096546 - Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

9. 9085531 - Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

10. 9073925 - Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof

11. 9067949 - [object Object]

12. 9045468 - 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

13. 9045501 - 5-HT3 receptor modulators, methods of making, and use thereof

14. 9045445 - Glycine transporter-1 inhibitors, methods of making them, and uses thereof

15. 8993765 - Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof